Have a feature idea you'd love to see implemented?
Let us know!
SGRY Surgery Partners Inc
Price (delayed)
$19.85
Market cap
$2.52B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.47
Enterprise value
$5.78B
Surgery Partners is headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for
Highlights
The gross profit has grown by 11% year-on-year
The revenue has grown by 10% YoY and by 3.3% from the previous quarter
SGRY's EPS has plunged by 81% from the previous quarter and by 42% YoY
The net income has dropped by 79% since the previous quarter and by 77% year-on-year
Key stats
What are the main financial stats of SGRY
Market
Valuations
Earnings
Shares outstanding
127.11M
Market cap
$2.52B
Enterprise value
$5.78B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.33
Price to sales (P/S)
0.84
EV/EBIT
36.88
EV/EBITDA
16.78
EV/Sales
1.94
Revenue
$2.99B
Gross profit
$705.6M
Net income
-$60.6M
EBIT
$156.7M
EBITDA
$344.5M
Free cash flow
$164.9M
Per share
Balance sheet
Liquidity
EPS
-$0.47
EPS diluted
-$0.47
Free cash flow per share
$1.31
Book value per share
$14.92
Revenue per share
$23.66
TBVPS
$21.18
Total assets
$7.53B
Total liabilities
$4.42B
Debt
$3.48B
Equity
$1.9B
Working capital
$460.6M
Debt to equity
1.83
Current ratio
1.8
Quick ratio
1.33
Net debt/EBITDA
9.45
Margins
Efficiency
Dividend
EBITDA margin
11.5%
Gross margin
23.6%
Net margin
-2%
Operating margin
10.9%
Return on assets
-0.8%
Return on equity
-3.1%
Return on invested capital
3.1%
Return on capital employed
2.3%
Return on sales
5.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SGRY stock price
How has the Surgery Partners stock price performed over time
Intraday
-6.19%
1 week
-3.83%
1 month
-2.5%
1 year
-38.85%
YTD
-6.24%
QTD
-6.24%
Financial performance
How have Surgery Partners's revenue and profit performed over time
Revenue
$2.99B
Gross profit
$705.6M
Operating income
$326.6M
Net income
-$60.6M
Gross margin
23.6%
Net margin
-2%
The net income has dropped by 79% since the previous quarter and by 77% year-on-year
SGRY's net margin has shrunk by 67% QoQ and by 54% YoY
The gross profit has grown by 11% year-on-year
The revenue has grown by 10% YoY and by 3.3% from the previous quarter
Growth
What is Surgery Partners's growth rate over time
Valuation
What is Surgery Partners stock price valuation
P/E
N/A
P/B
1.33
P/S
0.84
EV/EBIT
36.88
EV/EBITDA
16.78
EV/Sales
1.94
SGRY's EPS has plunged by 81% from the previous quarter and by 42% YoY
The stock's price to book (P/B) is 66% less than its 5-year quarterly average of 3.9 and 30% less than its last 4 quarters average of 1.9
The equity has declined by 5% year-on-year and by 2.9% since the previous quarter
The P/S is 35% below the 5-year quarterly average of 1.3 and 35% below the last 4 quarters average of 1.3
The revenue has grown by 10% YoY and by 3.3% from the previous quarter
Efficiency
How efficient is Surgery Partners business performance
Surgery Partners's ROE has plunged by 82% from the previous quarter and by 82% YoY
SGRY's return on assets has dropped by 60% since the previous quarter and by 60% year-on-year
SGRY's ROS is down by 19% YoY and by 17% from the previous quarter
SGRY's ROIC is down by 18% YoY and by 16% from the previous quarter
Dividends
What is SGRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SGRY.
Financial health
How did Surgery Partners financials performed over time
The total assets is 70% greater than the total liabilities
Surgery Partners's total liabilities has increased by 17% YoY and by 2.6% QoQ
The total assets is up by 11% year-on-year
SGRY's debt is 83% higher than its equity
The debt to equity has grown by 24% YoY and by 5% from the previous quarter
SGRY's debt is up by 18% YoY and by 2.6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.